Skip to main content

. 2017 Apr 20;2(8):e94086. doi: 10.1172/jci.insight.94086

A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene

Yonghe Ding, Pamela A Long, J Martijn Bos, Yu-Huan Shih, Xiao Ma, Rhianna S Sundsbak, Jianhua Chen, Yiwen Jiang, Liqun Zhao, Xinyang Hu, Jianan Wang, Yongyong Shi, Michael J Ackerman, Xueying Lin, Stephen C Ekker, Margaret M Redfield, Timothy M Olson, Xiaolei Xu

PMCID: PMC5396515 PMID: 28422763

Original citation: JCI Insight. 2016;1(14):e88797. https://doi.org/10.1172/jci.insight.88797

Citation for this corrigendum: JCI Insight. 2017;2(8):e94086. https://doi.org/10.1172/jci.insight.94086

In Table 2, the nucleotide change resulting in the p.F93F variant of DNAJB6 was incorrectly noted. The correct table is below.

Table 2. Summary of DNAJB6 variants identified in human cardiomyopathy patients (n = 325).

Open in a new tab

The authors regret the error.

Footnotes

See the related article at A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.

ACTIONS

RESOURCES